Patriot Investment Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Patriot Investment Management Group's BMY Position: Q2 2026 in Review
Patriot Investment Management Group reduced its Bristol-Myers Squibb (BMY) stake by 18% in Q2 2026, selling an estimated $52.8K and leaving 4,236 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #224.
Patriot Investment Management Group first reported a position in BMY in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.98M in Q1 2022. 971 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Patriot Investment Management Group held 4,236 shares of Bristol-Myers Squibb worth $244K as of Q2 2026.
- Patriot Investment Management Group sold 919 Bristol-Myers Squibb shares in Q2 2026, an estimated $52.8K.
- Bristol-Myers Squibb made up 0.01% of Patriot Investment Management Group's portfolio in Q2 2026, its #224 holding.
- Patriot Investment Management Group first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 30 quarters since.
- Patriot Investment Management Group's Bristol-Myers Squibb position peaked at $1.98M in Q1 2022.
- 971 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Patriot Investment Management Group's 13F filing for Q2 2026, filed 15 Jul 2026.